Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Amortization - Deferred ChargesCost of RevenueEBIATNon-Current ReceivablesOther Gross PP&E AdjustmentsReceivables - NetShares Repurchased
Ratios

Fennec Pharmaceuticals (FENC) Long-Term Debt Issuances (2022)

Fennec Pharmaceuticals (FENC) has disclosed Long-Term Debt Issuances for 4 consecutive years, with -$65000.0 as the latest value for Q4 2022.

  • For the quarter ending Q4 2022, Long-Term Debt Issuances changed N/A year-over-year to -$65000.0, compared with a TTM value of $24.9 million through Dec 2022, changed N/A, and an annual FY2023 reading of $5.0 million, down 79.96% over the prior year.
  • Long-Term Debt Issuances was -$65000.0 for Q4 2022 at Fennec Pharmaceuticals, down from $20.0 million in the prior quarter.
  • Across five years, Long-Term Debt Issuances topped out at $20.0 million in Q3 2022 and bottomed at -$65000.0 in Q4 2022.